RP

Recent Patents On Anti-cancer Drug Discovery

Recent Patents on Anti-Cancer Drug Discovery is an international, peer-reviewed journal on all aspects of anti-cancer drug discovery, published bimonthly in print and online by Bentham Science Publishers.

Looking to publish in Recent Patents On Anti-cancer Drug Discovery? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 4.1
Quartile Q2
Open Access Type Open
ISSN 1574-8928
eISSN 2212-3970
Invitation Only No
Cost Range Publication costs are supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.

Submission Instructions

Recent Patents On Anti-cancer Drug Discovery accepts the following article types. Click on an article type to view submission instructions.

Review Articles

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The copyright letter must confirm author approval for submission and publication of the manuscript.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured. The abstract must use explicit subheadings as inline or run-in headings in bold.
Manuscript Review Articles must be 6000-10000 words excluding figures, structures, photographs, schemes, and tables. Review Articles must be divided into prescribed sections including Title, Title page, Structured Abstract, Graphical Abstract, Keywords, Text Organization, Conclusion, List of Abbreviations if any, Consent for Publication, Availability of Data and Materials, Funding, Conflict of Interest, Acknowledgements, References, Appendices, Figures/Illustrations if any, Chemical Structures if any, Tables if any, and Supportive/Supplementary Material if any, and should conclude with a short section titled 'Current & Future Developments'. Manuscripts must include 6 to 8 keywords, a graphical abstract, an Authors' Contribution paragraph with a CRediT statement, conflict of interest and funding statements, a list of abbreviations if any, and disclosure of any significant use of AI tools.
References Review Articles must include 100 or more references. References must be in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and must not include abstracts, unpublished data, or personal communications in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with the article. Figures and tables must be embedded in the manuscript at their appropriate placement, and figures must also be provided as separate files for online submission. Figures and tables must be numbered sequentially in the order of citation and each table must include a self-explanatory title or caption.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Mini-Reviews

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must confirm that all authors approve the submission and publication of the manuscript.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings presented as inline or run-in headings in bold.
Manuscript Mini-Reviews must be 3000-6000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must be divided into the title page, abstract, and main text. The manuscript must include 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT statement, a conflict of interest statement, a funding declaration, a list of notations before the first paragraph of the full text, and disclosure of any significant AI use.
References Mini-Reviews must include 75 or more references. References must be in ACS or Vancouver style. References must be cited in the text in square brackets and abstracts, unpublished data, and personal communications must not be included in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with each article. Figures and tables must be embedded in the manuscript at their appropriate placement, and figures must also be uploaded as separate files. Figures and tables must be numbered consecutively in the order of citation and each table must include a self-explanatory title or caption.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Research Articles

Cover Letter A signed copyright letter is required with the manuscript. The letter must be submitted by the corresponding or principal author on behalf of all co-authors and must confirm that the manuscript has not been published previously and is not under consideration elsewhere.
Abstract An abstract is required. The structured abstract must not exceed 250 words. The abstract must be structured. The abstract must use the subheadings Introduction/Objective, Methods, Results, Discussion, and Conclusion or equivalent headings.
Manuscript Research Articles must be 4000-6000 words excluding figures, structures, photographs, schemes, and tables. Research Articles must be divided into Introduction, Materials and Methods, Results, Discussion, Conclusion, Current & Future Developments, List of Abbreviations, Ethics Approval and Consent to Participate, Human and Animal Rights, Consent for Publication, Availability of Data & Materials, Funding, Conflict of Interest, Acknowledgements, and References. The manuscript must include a graphical abstract, keywords, a list of abbreviations if any, and declarations for consent for publication, availability of data and materials, funding, conflict of interest, acknowledgements, and any use of AI tools.
References Research Articles must include 75 or more references. References must be submitted in ACS or Vancouver style. References must be complete, accurate, numbered in order of citation, cited in square brackets in the text, and fully formatted before submission.
Figures & Tables Figures and illustrations must be submitted as separate files and a PDF of the entire manuscript with all figures, tables, and structures embedded must also be included, while tables must be embedded in the text. Figures must be cited in sequence, have legends or captions, and tables must be numbered sequentially with self-explanatory titles and black cell borders.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Systematic Reviews

Cover Letter A signed copyright letter must be submitted by the corresponding author on behalf of all co-authors. The copyright letter must confirm author approval of the submission and publication of all versions of the manuscript.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings. Abstract should include Introduction/Objective, Methods, Results, Discussion, and Conclusion, or equivalent headings.
Manuscript Manuscript must be 4000–6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript should address the methods used for selecting, locating, extracting, and synthesizing data. Manuscript must include 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT statement, a conflict of interest statement, and disclosure of any significant AI tool use.
References Systematic Reviews must include 100 or more references. References must follow ACS or Vancouver style. References must be cited in the text with numbers in square brackets and abstracts, unpublished data, and personal communications must not appear in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with the article. Figures must be provided as separate files and also embedded in the manuscript, while tables must be embedded in the text according to their appropriate placement. Each table must include a self-explanatory title or caption and each figure must include a legend or caption.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Meta-Analyses

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must confirm that all listed authors approve the submission and publication of the manuscript.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings.
Manuscript Main text must be divided into the title page, abstract, and main text. Manuscript must include 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT author contribution statement, a conflict of interest statement, funding information, and disclosure of any significant use of AI tools.
References References must be submitted in ACS or Vancouver style. References must be cited in the text with square-bracketed numbers and must not include abstracts, unpublished data, or personal communications in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with the article. Figures must be uploaded as separate files and also embedded in the manuscript, while tables must be embedded in the text according to their appropriate placement. Each figure and table must be numbered consecutively, cited in the text in sequence, and accompanied by a legend or self-explanatory caption.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Randomized Drug Clinical Trial Studies

Cover Letter A signed copyright letter is required with submission. The copyright letter must be submitted by the corresponding author on behalf of all co-authors and include approval and consent-to-disclose declarations for human studies when applicable.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings in bold. The trial registry name, registration identification number, and registry URL must be included at the end of the abstract.
Manuscript Manuscript must be 4000-6000 words excluding figures, structures, photographs, schemes, and tables. Manuscript must clearly state an objective or hypothesis and include design and methods, main outcome measures, main results, a comment section discussing context and limitations, conclusions, and a 'Randomization and Masking' section within Methods. Manuscript must include 6 to 8 keywords, an 'Authors' Contribution' paragraph with a CRediT statement, funding and conflict of interest disclosures, a list of notations before the full text if used, and disclosure of significant AI tool use including how and which tool was used.
References Manuscript must include 50 or more references. References must use ACS or Vancouver style. References must be cited in the text using square-bracketed numbers and must not include abstracts, unpublished data, or personal communications in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with the article. Figures and tables must be embedded in the manuscript at their appropriate placement, while online submission also requires figure files to be provided separately. Figures must be numbered consecutively and cited in sequence with legends or captions provided, and tables must be numbered sequentially, cited in the text, and include a self-explanatory title or caption.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Short Communications

Cover Letter A signed copyright letter must be submitted with the manuscript. The copyright letter must be submitted by the corresponding author on behalf of all co-authors confirming that all authors approved the submission.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings presented as inline or run-in bold headings.
Manuscript Short Communications must be 2000-3000 words excluding figures, structures, photographs, schemes, and tables. The manuscript must be divided into the title page, abstract, and main text. The manuscript must include 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT statement, a conflict of interest statement, funding disclosure, and disclosure of significant AI tool use.
References Short Communications must include 25 or more references. References must be submitted in ACS or Vancouver style. References must be cited in the text with numbers in square brackets and online citations must include the date of access.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with each article. Figures and tables must be embedded in the manuscript text at their appropriate placement, and figures must also be provided as separate files for online submission. Figures and tables must be numbered consecutively in the order of citation and each table must include a title or caption while figure legends and captions must be provided.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Case Reports

Cover Letter A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors. The copyright letter must confirm author approval for submission and publication of the manuscript.
Abstract An abstract is required. Abstract must not exceed 250 words. Abstract must be structured with explicit subheadings.
Manuscript Case Reports must be 1500–2500 words excluding figures, structures, photographs, schemes, and tables. Manuscript must be divided into a title page, abstract, and main text. Manuscript must include 6 to 8 keywords, an Authors' Contribution paragraph with a CRediT statement, a conflict of interest statement, funding information, and disclosure of significant AI tool use.
References Case Reports must include 40 or more references. References must be submitted in ACS or Vancouver style. References must be cited in the text using square-bracketed numbers in order of first discussion, and abstracts, unpublished data, and personal communications must not appear in the reference list.
Figures & Tables There is no restriction on the number of figures or tables that can be included online with the article. Figures and tables must be embedded in the manuscript according to their appropriate placement, and figures must also be provided as separate files for online submission. Figures and tables must be numbered sequentially in the order of citation and each table must include a self-explanatory title or caption while figure legends and captions must be provided.
Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Recent Publications

A Comprehensive Review of Genistein and Chitosan: Mechanistic Foundations, Regulatory Roadmap, and Future Research Directions

Bishop Adhikari, D Nagasamy Venkatesh, Vivek Puri, Ameya Sharma, Prashant Nayak, Syed Suhaib Ahmed

10.2174/0115748928438838260406215239
View Publication

Patent Landscape and Technological Trajectory of Drug Delivery Systems for Overcoming Drug Resistance in Non-small Cell Lung Cancer

Feiyan Wu, Xinglinzi Tang, Xinyi Luo, Caizhi Li, Xin Lai, Danyang Li, Hang Li

10.2174/0115748928434923260422093655
View Publication

CAIX–HIF-1α Inhibition by 2-(4-Chlorophenyl)-3-(4-Ethoxyphenyl) Thiazolidin-4-one (BCS12) Activates Caspase Cascade and PARP Cleavage, Driving Mitochondrial Apoptosis in Hypoxic Breast Cancer

Gaurav Ranjan, Shakti Prasad Pattanayak, Priyashree Sunita

10.2174/0115748928441521260224055625
View Publication

Melanoma Metastasizing to the Breast: A Case Report

Xiaocheng Pan, Zichang Chen, Junhong Chen, Jiaxu Huang, Ruipei Chen, Gengcong Luo, Junbing He, Hongpeng Chen

10.2174/0115748928449521260410075051
View Publication

Multi-omics Analysis Uncovers TFRC/HMOX1-dependent Ferroptosis Mediating Celastrol’s Anti-invasive/Metastatic Effects on Esophageal Squamous Cell Carcinoma

Yulong Zha, Tao Shen, Huayu Luo, Yu Zhang, Hongzheng Ren

10.2174/0115748928434600260226051559
View Publication

Frequently asked questions

How long does it take to publish?

Quick Track allows online publication within 2 weeks of receipt of the final approved galley proofs. Total publication time from first receipt of the manuscript to online publication is 10 weeks under Quick Track, subject to acceptance and author revisions within one week. Revised papers are usually requested within 15 days, and revision time may vary from 1 to 4 weeks depending on the nature of the revision. Proofs should be returned within 48 hours.

Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Is a cover letter required?

A signed copyright letter must be submitted with the manuscript by the corresponding author on behalf of all co-authors, confirming that the manuscript has not been published previously and is not under consideration elsewhere.

Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

What are the publication costs?

Publication costs are supported by an Article Processing Charge (APC), typically paid by the author's institution, funding body, or the authors themselves.

Reformat to Recent Patents On Anti-cancer Drug Discovery using Livewrite Premium

Research Topics

Diverse Scientific and Economic Studies Legal Cases and Commentary Intellectual Property and Patents Cancer Mechanisms and Therapy Ferroptosis and cancer prognosis Cancer, Hypoxia, and Metabolism Cancer Research and Treatment Cancer Research and Treatments 14-3-3 protein interactions Nanoparticle-Based Drug Delivery Cell death mechanisms and regulation Cancer, Lipids, and Metabolism Human auditory perception and evaluation Cancer Immunotherapy and Biomarkers Cancer Treatment and Pharmacology Synthesis and biological activity Lung Cancer Treatments and Mutations Histone Deacetylase Inhibitors Research Cancer, Stress, Anesthesia, and Immune Response Computational Drug Discovery Methods HER2/EGFR in Cancer Research Cancer Cells and Metastasis Biological Research and Disease Studies Advanced Breast Cancer Therapies Cancer-related Molecular Pathways